Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 13.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 13.52 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,523.2 Cr -2.5% 9.8% 44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-2.5%

9.8%

44.7%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses